Journal article
A competing-risk approach to modelling length of stay in severe malaria patients in South-East Asia and the implications for planning of hospital services
- Abstract:
- Malaria burdens global health systems, and management with limited resources requires robust treatment guidelines and comprehensive planning. Expected length of stay (LOS) is useful in health-system planning, and factors influencing it can be targeted to reduce admission time and optimise service delivery.A secondary survival analysis of 1217 adult severe malaria patients from the South-East Asia Quinine Artesunate Malaria Trial, using a competing-risk approach.Median LOS was five days and time to discharge six days. 80% of patients were discharged, 70.2% within a week. 95.4% of deaths occurred within seven days. Compared to quinine, artesunate increased discharge incidence (subdistribution-hazard ratio 1.24 (1.09-1.40) p=0.001) and decreased incidence of death (0.60 (0.46-0.80) p<0.001). Cumulative incidence of discharge was decreased, and death increased, by low Glasgow coma scale (discharge: 1.08 (1.06-1.11) p<0.001, death: 0.85 (0.82-0.89) p<0.001), high blood urea-nitrogen (discharge: 0.99 (0.99-0.995) p<0.001, death: 1.00 (1.00-1.01) p=0.012), acidotic base-excess (discharge: 1.05 (1.03-1.06) p<0.001, death: 0.90 (0.88-0.93) p<0.001), and development of shock (discharge: 0.25 (0.13-0.47) p<0.001, death: 2.14 (1.46-3.12) p<0.001) or coma (discharge: 0.46 ( 0.32-0.65) p<0.001, death: 2.30 (1.58-3.36) p<0.001). Conventional Kaplan-Meier survival analysis overestimated cumulative incidence compared to competing-risk models.Clinical factors on admission and during hospitalisation influence LOS in severe malaria, offering targets to improve health and service efficiency. Artesunate has the potential to increase LOS, which should be accounted for in service-planning. Death in-hospital is a competing risk for discharge, and should be considered in LOS models to reduce overestimation of risk and misrepresentation of associations.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 284.1KB, Terms of use)
-
- Publisher copy:
- 10.1093/cid/ciy211
Authors
- Publisher:
- Oxford University Press
- Journal:
- Clinical Infectious Diseases More from this journal
- Volume:
- 67
- Issue:
- 7
- Pages:
- 1053–1062
- Publication date:
- 2018-03-19
- Acceptance date:
- 2018-03-16
- DOI:
- EISSN:
-
1537-6591
- ISSN:
-
1058-4838
- Pmid:
-
29562258
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:830720
- UUID:
-
uuid:ecca7b51-401c-4f3a-beb1-a21e775d271c
- Local pid:
-
pubs:830720
- Source identifiers:
-
830720
- Deposit date:
-
2018-04-04
- ARK identifier:
Terms of use
- Copyright holder:
- Keene, et al
- Copyright date:
- 2018
- Notes:
- © Keene, et al 2018. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record